EMEA-000687-PIP01-09-M02 - paediatric investigation plan
Pandemic influenza vaccine (H1N1) (split virion, inactivated, adjuvanted), containing antigen equivalent to Influenza A/California/7/2009
PIPHuman
GlaxoSmithKline Biologicals S.A. (UK)
E-mail: eu.paediatric-plans@gsk.com
Tel.: +1 438 899 8201